Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Gottschalk

Showing results (21-30 of 227) with videos related to

Pageof 23
Sort By:
Cell Reports. Medicine|February 22, 2023
A tour de force provides novel insights into CD19-CAR T cell resistance mechanismsAimee C Talleur, Stephen Gottschalk
Blood|October 21, 2021
Expect the unexpected: piggyBac and lymphomaMatthew H Wilson, Stephen Gottschalk
Blood Cancer Discovery|January 11, 2022
Employing Synthetic T-cell Biology to Target AML without On-Target/Off-Cancer ToxicityM Paulina Velasquez, Stephen Gottschalk
Current Topics in Microbiology and Immunology|October 3, 2015
Adoptive T-Cell ImmunotherapyStephen Gottschalk, Cliona M Rooney
Blood|January 7, 2017
Targeting CD19: the good, the bad, and CD81Mireya Paulina Velasquez, Stephen Gottschalk
Nature Immunology|June 22, 2026
Costimulation drives CAR-T cell division fateAdeleye O Adeshakin, Stephen Gottschalk
Immunotherapy|March 15, 2011
Cellular immunotherapy for high-grade gliomaK H Chow, Stephen Gottschalk
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 4, 2014
Harnessing the immune system to potentiate oncolyticsStephen Gottschalk, Cliona M Rooney
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 19, 2026
Biomarkers for Diagnosis, Risk Stratification, and Immunotherapy of Pediatric Solid TumorsEwa Koscielniak, Katie Janeway, Stephen Gottschalk
EJC Paediatric Oncology|July 3, 2024
CAR T cells redirected to B7-H3 for pediatric solid tumors: Current status and future perspectivesRebecca Epperly, Stephen Gottschalk, Christopher DeRenzo
Pageof 23

Showing results (21-30 of 227) with videos related to

Sort By:
Pageof 23
Cell Reports. Medicine|February 22, 2023
A tour de force provides novel insights into CD19-CAR T cell resistance mechanismsAimee C Talleur, Stephen Gottschalk
Blood|October 21, 2021
Expect the unexpected: piggyBac and lymphomaMatthew H Wilson, Stephen Gottschalk
Blood Cancer Discovery|January 11, 2022
Employing Synthetic T-cell Biology to Target AML without On-Target/Off-Cancer ToxicityM Paulina Velasquez, Stephen Gottschalk
Current Topics in Microbiology and Immunology|October 3, 2015
Adoptive T-Cell ImmunotherapyStephen Gottschalk, Cliona M Rooney
Blood|January 7, 2017
Targeting CD19: the good, the bad, and CD81Mireya Paulina Velasquez, Stephen Gottschalk
Nature Immunology|June 22, 2026
Costimulation drives CAR-T cell division fateAdeleye O Adeshakin, Stephen Gottschalk
Immunotherapy|March 15, 2011
Cellular immunotherapy for high-grade gliomaK H Chow, Stephen Gottschalk
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 4, 2014
Harnessing the immune system to potentiate oncolyticsStephen Gottschalk, Cliona M Rooney
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 19, 2026
Biomarkers for Diagnosis, Risk Stratification, and Immunotherapy of Pediatric Solid TumorsEwa Koscielniak, Katie Janeway, Stephen Gottschalk
EJC Paediatric Oncology|July 3, 2024
CAR T cells redirected to B7-H3 for pediatric solid tumors: Current status and future perspectivesRebecca Epperly, Stephen Gottschalk, Christopher DeRenzo
Pageof 23